Biggest News Aggregation in the World
๐Ÿ“ฐ Van Cutsem News

Page 4 - Van Cutsem News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Van Cutsem. Real-time updates on events, politics, business and more.

BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA®

BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA®Sep 19, 2023 6:15 AMEuropean Commission approves TEVIMBRA for previously treated advanced or metastatic esophageal squamous cell carcinoma (ESCC)U.S. FDA accepts Biologics License Ap...
New Zealand United Kingdom United States Mark Lanasa Josh Neiman Van Cutsem

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumors

AstraZeneca and Daiichi Sankyo’s ENHERTU showed an objective response rate of 37.1% in the overall population of the DESTINY-PanTumor02 Phase II trial ENHERTU is the first therapy to show... | June 5, 2023
United States United Kingdom Cristian Massacesi Daiichi Sankyo Van Cutsem Mark Rutstein

Encorafenib Plus Cetuximab/Binimetinib Displays Activity, Safety in BRAF V600E–mutant mCRC

Triplet therapy consisting of encorafenib, cetuximab, and binimetinib demonstrated activity and manageable safety as first-line treatment for patients with BRAF V600Eโ€“mutated metastatic colorectal cancer.
Van Cutsem Dimension Or European Organization For Research Cancer Symposium Level Euroqol European Organization Cancer Qol Questionnaire Core

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science